Lombard Odier Asset Management (Europe) Ltd
Position in GILD — Gilead Sciences, Inc.
CIK 1535784
LONDON, X0
Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,727,630
-$727,170 QoQ
Shares Held
12,396
-38.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lombard Odier Asset Management (Europe) Ltd holds $66,383,381 across 3 Drug Manufacturers - General names.
All Filings in GILD
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,727,630 | 12,396 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,454,800 | 20,000 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $2,217,400 | 20,000 | Shares | Other | 2025-08-14 | |
| 2023-12-31 | $1,574,186 | 19,432 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $1,468,149 | 19,591 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $2,253,526 | 29,240 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $3,387,001 | 40,822 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $3,810,023 | 44,380 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $2,935,148 | 47,579 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $3,105,828 | 50,248 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $2,451,955 | 41,244 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $2,374,201 | 32,698 | Shares | Other | 2022-04-29 | |
| 2020-12-31 | $891,552 | 15,303 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $717,269 | 11,351 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $873,345 | 11,351 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $848,600 | 11,351 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||